BPC-157 Protocol Guide: Dosing, Reconstitution & Injection Sites

BPC-157 is S-tier on our Peptide Rankings — and for good reason. The research behind it is genuinely compelling: accelerated healing of tendons, ligaments, muscle, and gut tissue; neuroprotective effects; anti-inflammatory action. But "compelling research" and "knowing how to actually use it" are different problems. This guide solves the second one.

For the full science — mechanisms, studies, what conditions it's been tested on — read the BPC-157 Complete Guide. This article is the practical how-to: reconstitution, dosing, injection technique, cycling, and safety.

What You Need Before You Start

BPC-157 is sold as lyophilized (freeze-dried) powder in sealed vials. You'll need a few items before you can use it:

• BPC-157 vial — typically 2mg, 5mg, or 10mg. See our Peptide Supplier Buyer's Guide for sourcing guidance.
• Bacteriostatic water (BAC water) — the reconstitution solvent. Do not use regular sterile water (no preservative, shorter shelf life) or tap water.
• Insulin syringes — 1mL, 29–31 gauge, 5/16" or 1/2" needle. These are the standard tool for both drawing and injecting.
• Alcohol swabs — 70% isopropyl. Swab vial tops and injection sites.
• Sharps container — do not recap and dispose of loose needles.

Reconstitution: Step-by-Step

Reconstitution is simply dissolving the powder in bacteriostatic water to create an injectable solution. The process takes about two minutes.

1. Wash your hands thoroughly with soap and water.
2. Swab the vial tops — both the BPC-157 vial and the BAC water vial — with an alcohol swab. Let dry 10–15 seconds.
3. Draw BAC water into a fresh insulin syringe. The volume depends on your target concentration (see table below).
4. Inject BAC water into the peptide vial slowly — angle the needle so the water runs down the side of the glass wall, not directly onto the powder. This prevents foaming and degradation.
5. Swirl gently for 20–30 seconds. Do not shake or vortex.
6. Inspect the solution — it should be clear and colorless. Discard if cloudy, particulate, or discolored.

Concentration Calculation Table

The concentration you mix determines how many units (marks on the syringe) deliver your target dose. Here are the most practical configurations:

Tip: The 1,000mcg/mL concentration (1mL BAC water per 1mg of peptide) is the most common because every 0.1mL is exactly 100mcg — easy mental math at injection time.

Storage Guidelines

• Unmixed powder: Room temperature (cool, dark, dry) for up to 12–24 months if sealed. Refrigeration optional but extends shelf life.
• Reconstituted solution: Refrigerate at 2–8°C. Use within 30 days. Label the vial with the reconstitution date.
• Do not freeze reconstituted solution — ice crystal formation degrades the peptide.
• Protect from light: Keep vials away from direct sunlight and UV.

Dosing Protocols

Standard Dose Range

The standard human dosing range for BPC-157 is 250–500mcg per day. Most users report good outcomes at 250mcg/day; those targeting musculoskeletal injuries often go to 500mcg/day during active healing phases.

Dosing is typically once daily. Some protocols split the dose (125–250mcg morning + 125–250mcg evening), which may improve coverage for systemic effects, though there's no strong evidence that split dosing outperforms once-daily administration.

Systemic vs. Local Injection

The injection location changes what BPC-157 optimizes for:

• Systemic (subcutaneous, away from injury): For gut repair, general anti-inflammatory effects, neuroprotection, or when injury site is inaccessible. Inject in abdomen or thigh. The peptide circulates and acts systemically.
• Local (near injury site): For acute musculoskeletal injury — tendon, ligament, muscle tear — inject subcutaneously adjacent to the injury. Research suggests higher local concentrations at the injury site accelerate tissue repair. Do not inject directly into tendons, joints, or cartilage.

Cycling Patterns

BPC-157 does not have the receptor downregulation concerns of peptides like GHRPs, so strict cycling is less critical. The two most common protocols are:

• 4 weeks on / 2 weeks off: Suitable for ongoing use or mild/chronic conditions. Run 4-week cycles with 2-week breaks between them.
• 8 weeks continuous / 4 weeks off: Common for acute injuries or more intensive healing phases. Higher end of the dose range (400–500mcg/day) is often used.

For acute injury, a 4–6 week protocol is typically sufficient to observe significant tissue response. For gut-related conditions (IBD, leaky gut), longer protocols of 8–12 weeks are more common in anecdotal reports.

A Note on Oral BPC-157

Animal research has shown that orally administered BPC-157 retains activity for gut-specific conditions. In rodent models of IBD, gastric ulcers, and intestinal permeability, oral administration produced results comparable to injectable in gut tissue — which makes mechanistic sense given BPC-157's original isolation from gastric juice.

For gut conditions specifically, oral BPC-157 is a reasonable option with a more convenient administration route. For musculoskeletal injuries, systemic inflammation, or neurological applications, injectable remains the standard — oral bioavailability for non-GI systemic effects is not well established in human data.

Injection Site Guide

Subcutaneous Injection — How To

Subcutaneous (subQ) injection goes into the fat layer just below the skin, not into muscle. This is appropriate for the volumes used with BPC-157 (0.1–0.5mL).

1. Swab the injection site with an alcohol swab. Let dry completely — wet alcohol stings.
2. Pinch a fold of skin to lift the fat layer away from muscle.
3. Insert the needle at a 45° angle (or 90° if using a very short 5/16" needle).
4. Release the pinch if needed. Inject the solution slowly — over 5–10 seconds.
5. Withdraw the needle smoothly. Apply light pressure with a clean swab if needed.
6. Dispose of the needle in a sharps container. Do not recap.

Site Options and Rotation

Abdomen: The most common site. Pinch a fold 2–3 inches to the side of the navel. Avoid the navel itself. Good fat layer, easy to reach, minimal nerve endings. Best for systemic protocols.

Thigh (outer/front): The outer or front surface of the thigh (vastus lateralis area). Good option when abdomen is sore or bruised from rotation. Easy self-administration.

Deltoid (upper arm): The fatty area just below the shoulder cap. Less tissue volume than abdomen, so better suited to smaller injection volumes.

Rotation matters. Injecting the same spot repeatedly causes lipodystrophy — localized fat atrophy or thickening. Establish a rotation pattern across at least 3–4 sites.

Local Injection for Injury Sites

For targeted tendon, ligament, or muscle injuries, inject subcutaneously adjacent to (not into) the injury. The goal is local tissue concentration, not direct injection into the affected structure.

• Knee: Inner or outer aspect of the knee, in the subcutaneous tissue above the joint line.
• Shoulder: Anterior or lateral deltoid area, away from the joint itself.
• Elbow: Lateral or medial epicondyle area — inject over the affected tendon insertion.
• Achilles / ankle: Posterior lower leg, subcutaneous tissue adjacent to the tendon.

If targeting a deep joint or you're uncertain about anatomy near a specific injury, consult a sports medicine or regenerative medicine provider. Many now offer peptide protocol guidance.

Safety: Side Effects, Contraindications & Drug Interactions

Side Effects

BPC-157 has one of the cleaner safety profiles among research peptides. Animal studies have not identified a toxic dose, and its origins as a fragment of a naturally occurring gastric protein suggest low inherent toxicity. Human clinical trial data remains limited.

Commonly reported side effects at standard doses:

• Injection site irritation: Minor redness, swelling, or bruising. Usually resolves within 24 hours. Rotation reduces this.
• Nausea: Typically at higher doses or when injecting on an empty stomach. Usually mild and transient.
• Fatigue or drowsiness: Reported by a subset of users, particularly early in a protocol.
• Vivid dreams: Anecdotally reported; mechanism unclear.

Contraindications

• Active malignancy: BPC-157's pro-angiogenic properties raise theoretical concern in cancer contexts. Oncology patients should avoid without physician oversight.
• Pregnancy and breastfeeding: No safety data exists. Avoid.
• Recent surgery: Avoid local injection near recent surgical sites without provider guidance.

Drug Interactions

• Anticoagulants (warfarin, apixaban, rivaroxaban): BPC-157 has demonstrated anti-thrombotic effects in animal models. Combining with blood thinners warrants caution and monitoring.
• NSAIDs: Animal data suggests BPC-157 may partially counteract NSAID-induced gut damage — a potentially beneficial interaction, not established in humans.

When to Consult a Provider

Consider working with a sports medicine or regenerative medicine provider if:

• You have an active or recent cancer diagnosis.
• You're on anticoagulation therapy.
• You have an autoimmune condition.
• You're targeting a complex joint injury that may benefit from ultrasound-guided injection.
• You're stacking multiple peptides.

Sourcing: What to Look For

Peptide quality varies dramatically across suppliers. With BPC-157, potency, purity, and sterility matter — contaminated injectable product carries real infection risk.

Key verification criteria:

• Third-party HPLC and mass spectrometry testing: Every reputable supplier provides CoAs (Certificates of Analysis) from independent labs verifying purity ≥98%.
• Endotoxin testing: Critical for injectable peptides. LAL endotoxin tests verify the product is safe for injection.
• Sterile manufacturing: Confirms the lyophilized product was prepared under sterile conditions.

Our Peptide Supplier Buyer's Guide ranks current suppliers by these criteria and flags vendors to avoid — updated post the Peptide Sciences shutdown.

Frequently Asked Questions

✦ Our Book

The Science of Wellness

Ten evidence-based chapters covering peptides, longevity, sleep, nutrition, and more — written by WellSourced. No hype. No agenda. Just the science.

Get the Book on Amazon →